A practical guide to essential care for women after 50, with health, wellness, and prevention tips that help maintain quality ...
Travere Therapeutics, Inc., announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) ...